Analysis of Normal-Tumour Tissue Interaction in Tumours: Prediction of Prostate Cancer Features from the Molecular Profile of Adjacent Normal Cells

TGF-β1 Reverses Inhibition of COX-2 With NS398 and Increases Invasion in Prostate Cancer Cells

(2010) Qiang Ding et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection

(2010) Jennifer L Gregg et al.   BMC CANCER

Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis

(2009) Konstantin Gaengel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

New Molecular Classifications of Breast Cancer

(2009) M. Cianfrocca et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

(2009) Janine T. Erler et al.   CANCER CELL

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

(2009) John M.L. Ebos et al.   CANCER CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

A Loss-of-Function Polymorphism in the Propeptide Domain of the LOX Gene and Breast Cancer

(2009) C. Min et al.   CANCER RESEARCH

Transforming growth factor beta (TGF-β) and inflammation in cancer

(2009) Brian Bierie et al.   CYTOKINE & GROWTH FACTOR REVIEWS

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop

(2009) Oscar Gonzalez-Moreno et al.   EXPERIMENTAL CELL RESEARCH

TGF-ß signaling, tumor microenvironment and tumor progression: the butterfly effect

(2009) Amit Joshi   Frontiers in Bioscience-Landmark

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling

(2009) A H Palamakumbura et al.   ONCOGENE

Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor

(2009) Sudeep K. Bose et al.   PROSTATE

Optimizing molecular signatures for predicting prostate cancer recurrence

(2009) Yijun Sun et al.   PROSTATE

Involvement of Cyr61 in growth, migration and metastasis of prostate cancer cells

(2008) Z-J Sun et al.   BRITISH JOURNAL OF CANCER

CYR61 and  V 5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma

(2008) Y. Monnier et al.   CANCER RESEARCH

NDRG3 is an androgen regulated and prostate enriched gene that promotesin vitroandin vivoprostate cancer cell growth

(2008) Weiqun Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer

(2008) Pirus Ghadjar et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Defining Increased Future Risk for Prostate Cancer: Evidence From a Population Based Screening Cohort

(2008) Fritz H. Schröder et al.   JOURNAL OF UROLOGY

Role of the renin–angiotensin system in prostate cancer

(2008) L. Chow et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Angiotensin II Induces Oxidative Stress in Prostate Cancer

(2008) H. Uemura et al.   MOLECULAR CANCER RESEARCH